• OUTLOOK ARENA
  • VIEWS ON NEWS
  • DECEMBER 23, 2000

Sectoral funds – Weekly roundup

This week saw both the major market indices tumbling. The BSE Sensex plunged by 6.4% to close at 3,905 points, while the S&P CNX Nifty fell by 5.8% to close at 1,240 points.

Open-ended, IT Schemes NAV
(Rs)
Last
week
Last
month
Last
year
*CAGR
Since inception
K P Internet Opport.(Gr)6.4-10.1%-5.8%0.0%-32.8%
Birla IT Fund (Gr)13.7-10.6%-10.2%-41.5%6.7%
DSP ML Tech.com (Gr)6.8-11.8%-8.4%0.0%-21.0%
Pru ICICI Tech. (Gr)5.1-11.9%-6.7%0.0%-47.9%
UTI Sector- Software14.4-12.2%-8.1%-14.3%23.8%
Sun F&C Emerg Tech (Gr)5.8-12.6%-5.1%0.0%-32.0%
K Tech5.9-12.8%-8.2%0.0%-25.1%
Magnum Sector Funds-IT12.1-12.9%-11.8%-39.3%58.4%
K P Infotech (Gr)22.9-13.0%-11.1%-25.4%96.3%
IL&FS eCOM Fund (Gr)5.0-13.5%-8.8%0.0%-63.3%
Tata IT Sector Fund8.7-13.9%-12.7%-33.6%13.5%
Alliance New Millenn (Gr)7.3-14.1%-9.1%0.0%-52.2%
*CAGR=Compounded Annual Growth Rate

IT stocks were major losers over the week. Consequently all IT funds have performed poorly, churning out negative returns. IT majors like Infosys, Satyam and NIIT were top losers on both the indices. Infosys fell 19%, Satyam - 15% and NIIT - 14%. This slump was largely due to heavy selling by the foreign institutional investors (FIIs).

Open-ended, Pharma Schemes NAV
(Rs)
Last
week
Last
month
Last
year
*CAGR
Since inception
UTI Sector-Pharma11.1-4.0%3.0%-20.7%-4.0%
Magnum Sector Funds-Pharma9.9-5.2%1.4%-34.0%-1.1%
K P Pharma (Gr)9.9-5.4%5.0%-33.0%3.8%
*CAGR=Compounded Annual Growth Rate

The mood in pharma stocks was no exception and mirrored the mood in IT stocks. As a result NAVs (net asset values) of pharma funds have also witnessed negative growth. Major losers in the pharma sector were Ranbaxy, Dr. Reddys, Novartis, and Glaxo.

Open-ended, FMCG Schemes NAV
(Rs)
Last
week
Last
month
Last
year
*CAGR
Since inception
Pru ICICI FMCG (Gr)10.2-1.9%6.4%-15.6%-0.5%
Magnum Sector Funds-FMCG8.4-2.8%3.8%-34.8%-10.0%
K P FMCG (Gr) 12.1-3.3%8.0%-12.6%13.6%
*CAGR=Compounded Annual Growth Rate

There was selective buying in FMCG (fast moving consumer goods) stocks. Hindustan Lever and Nestle were top FMCG gainers, whereas Colgate and ITC witnessed a decline. After a couple of weeks in the limelight, FMCG stocks seem to have lost their sheen and have returned to their old ways.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407